Orosomucoid: Difference between revisions
Brian Blank (talk | contribs) No edit summary |
m (Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +)) |
||
Line 39: | Line 39: | ||
{{SI}} | {{SI}} | ||
==Overview== | ==Overview== | ||
'''Orosomucoid''' is an [[alpha-globulin]]. | '''Orosomucoid''' is an [[alpha-globulin]]. | ||
Line 54: | Line 54: | ||
[[Category:Proteomics]] | [[Category:Proteomics]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 14:34, 20 August 2012
orosomucoid 1 | |
---|---|
Identifiers | |
Symbol | ORM1 |
Entrez | 5004 |
HUGO | 8498 |
OMIM | 138600 |
RefSeq | NM_000607 |
UniProt | P02763 |
Other data | |
Locus | Chr. 9 q31-qter |
orosomucoid 2 | |
---|---|
Identifiers | |
Symbol | ORM2 |
Entrez | 5005 |
HUGO | 8499 |
OMIM | 138610 |
RefSeq | NM_000608 |
UniProt | P19652 |
Other data | |
Locus | Chr. 9 q31-qter |
WikiDoc Resources for Orosomucoid |
Articles |
---|
Most recent articles on Orosomucoid Most cited articles on Orosomucoid |
Media |
Powerpoint slides on Orosomucoid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Orosomucoid at Clinical Trials.gov Clinical Trials on Orosomucoid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Orosomucoid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Orosomucoid Discussion groups on Orosomucoid Patient Handouts on Orosomucoid Directions to Hospitals Treating Orosomucoid Risk calculators and risk factors for Orosomucoid
|
Healthcare Provider Resources |
Causes & Risk Factors for Orosomucoid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Overview
Orosomucoid is an alpha-globulin.
External links
- Orosomucoid at the US National Library of Medicine Medical Subject Headings (MeSH)